Penny stocks: is this CBD stock one to buy or avoid?

There are lots of CBD penny stocks out there. Jabran Khan explores one pick for his portfolio and decides whether he should invest or avoid.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There are now a few CBD penny stocks on the FTSE index. Is Zoetic International (LSE:ZOE) one to buy or avoid for my portfolio?

Riding the CBD wave

According to the Centre for Medicinal Cannabis (CMC), six million people in the UK have tried CBD. Unlike the illegal form of marijuana, it doesn’t contain tetrahydrocannabinol (THC) – that’s the part responsible for the ‘high’ from the plant. CBD is marketed as having health and wellness benefits.

Zoetic describes itself as a premium CBD company. It creates, markets, and sells CBD-based products such as oils, soft gels, and cosmetic products. Its most successful product is an alternative tobacco brand called Chill, which is making huge strides in the US market. Zoetic recently signed a landmark deal with the Asian America Trade Association, which represents convenience stores based in the US, for promoting its Chill brand.

Among the CBD penny stocks out there, I am reviewing Zoetic due to its position in the market and achievements. It has won multiple awards for its products and is recognised worldwide for its product quality.

Share price and performance

As I write, Zoetic shares are trading for 51p per share. In the past 12 months, its share price has increased by over 500%. This time last year shares were trading for 8p per share.

I believe the rise in share price has been triggered by Zoetic’s alternative tobacco brand Chill. In a trading update in October 2020, Zoetic announced successful trials of Chill products prompting a share price rise.

In its most recent trading update in April, it confirmed by July 2021 Chill products will be on sale in 3,500 stores. Additionally, Chill branded products will be entering the UK market for the first time and being made available to consumers. Furthermore, new products such as anti-ageing creams and other innovations were in the pipeline as well as new distribution deals internationally. It all sounds really promising but what is actually selling? Well, it seems not a lot just yet.

Should I invest in CBD penny stocks?

I admit as a penny stock Zoetic seems to be doing the right things from a product perspective. There are promising signs. But, there are lots of risks. Firstly, Zoetic only moved towards being a wholly CBD focussed firm in 2019. Prior to that, it was an oil and gas business called Highlands Natural Resources. This resulted in a loss of a revenue stream and therefore financials have not been the most impressive to date. For example, between April and September last year, only £55,000 worth of goods were sold.

Next, Zoetic has had to use credit facilities to keep the lights on in the past. It opened a credit facility worth £35m with LDA Capital but has since managed to cancel this due an uptake in subscriptions and growth.

Finally, the overall promotion and medical cannabis market has been hampered by the lack of clinical evidence showing its effectiveness in treating various conditions. This will cause volatility in the market and performance of any stock, especially a penny stock, so this is a big risk.

Investing in CBD penny stocks is not for me. I would not invest in Zoetic today as I feel it is too risky and perhaps too early. Having promising products does not pay the bills, sales do and currently Zoetic is unprofitable. I will keep an eye on developments, however.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jabran Khan has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

How would I start planning my Stocks and Shares ISA for 2025? With this super-solid growth stock

I can’t think of a better way to prepare for a new year than opening a fresh Stock and Shares…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Down 26% to just £4, Glencore’s share price looks cheap to me right now

Market pessimism over China’s economic growth has helped push Glencore’s share price down but I think this is overdone, leaving…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in November [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Why now could be the time to get ready for a stock market crash

Both the FTSE 100 and the S&P 500 climbed after the US election results. But Stephen Wright thinks now is…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

A UK share and an ETF that could soar following Trump’s election win

Donald Trump's White House return poses huge uncertainty for the global economy. But this UK share and ETF could gain…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

2 FTSE stocks that demonstrate the best (and worst) of the AIM market

Our writer looks at the performance of two very different FTSE stocks that highlights the pros and cons of investing…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With a P/E ratio of 8 and selling for pennies, is this FTSE 250 share a bargain?

Christopher Ruane digs into a cheap-looking FTSE 250 share that sells an iconic product and considers whether it's really a…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Could the stock market crash in 2025?

Our writer considers some possible drivers for a stock market crash. Rather than try to time it, he's wondering how…

Read more »